DOCU vs SLNO · P/E 15, rev $1.71B vs P/E 27, $2.76B cap
DocuSign Inc (DOCU) versus Soleno Therapeutics Inc (SLNO) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
Latest reported DOCU revenue for 2026-07-31 was $1.71B. Net income was $155.9M. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
SLNO does not have a complete income-statement cache yet.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. SLNO currently screens at market cap $2.76B and trailing P/E 27.5.
Not investment advice. Open the DOCU and SLNO stock pages for the full models.
Not investment advice.